IONS logo

Ionis Pharmaceuticals (IONS) Accounts payable

annual accounts payable:

$42.96M+$16.94M(+65.07%)
December 31, 2024

Summary

  • As of today (May 29, 2025), IONS annual accounts payable is $42.96 million, with the most recent change of +$16.94 million (+65.07%) on December 31, 2024.
  • During the last 3 years, IONS annual accounts payable has risen by +$31.06 million (+260.92%).
  • IONS annual accounts payable is now at all-time high.

Performance

IONS Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSbalance sheet metrics

quarterly accounts payable:

$17.46M-$25.51M(-59.37%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS quarterly accounts payable is $17.46 million, with the most recent change of -$25.51 million (-59.37%) on March 31, 2025.
  • Over the past year, IONS quarterly accounts payable has increased by +$4.37 million (+33.44%).
  • IONS quarterly accounts payable is now -59.37% below its all-time high of $42.96 million, reached on December 31, 2024.

Performance

IONS quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

IONS Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+65.1%+33.4%
3 y3 years+260.9%+8.3%
5 y5 years+167.4%-17.6%

IONS Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+260.9%-59.4%+210.9%
5 y5-yearat high+260.9%-59.4%+210.9%
alltimeall timeat high+4196.4%-59.4%+4264.0%

IONS Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$17.46M(-59.4%)
Dec 2024
$42.96M(+65.1%)
$42.96M(+374.6%)
Sep 2024
-
$9.05M(-2.1%)
Jun 2024
-
$9.24M(-29.3%)
Mar 2024
-
$13.08M(-49.7%)
Dec 2023
$26.03M(+45.2%)
$26.03M(+363.5%)
Sep 2023
-
$5.62M(-76.6%)
Jun 2023
-
$24.02M(+128.8%)
Mar 2023
-
$10.50M(-41.4%)
Dec 2022
$17.92M(+50.5%)
$17.92M(-12.8%)
Sep 2022
-
$20.55M(+98.5%)
Jun 2022
-
$10.35M(-35.8%)
Mar 2022
-
$16.13M(+35.5%)
Dec 2021
$11.90M(-30.8%)
$11.90M(+42.4%)
Sep 2021
-
$8.36M(-43.0%)
Jun 2021
-
$14.66M(+54.2%)
Mar 2021
-
$9.51M(-44.7%)
Dec 2020
$17.20M(+7.0%)
$17.20M(+6.0%)
Sep 2020
-
$16.22M(+119.0%)
Jun 2020
-
$7.41M(-65.0%)
Mar 2020
-
$21.17M(+31.8%)
Dec 2019
$16.07M(-43.9%)
$16.07M(+22.2%)
Sep 2019
-
$13.15M(-15.9%)
Jun 2019
-
$15.63M(+17.2%)
Mar 2019
-
$13.33M(-53.5%)
Dec 2018
$28.66M(+15.2%)
$28.66M(+111.1%)
Sep 2018
-
$13.58M(+2.1%)
Jun 2018
-
$13.29M(-3.9%)
Mar 2018
-
$13.83M(-44.4%)
Dec 2017
$24.89M(+17.8%)
$24.89M(+5.8%)
Sep 2017
-
$23.52M(+77.3%)
Jun 2017
-
$13.27M(-42.9%)
Mar 2017
-
$23.24M(+10.0%)
Dec 2016
$21.12M(-25.5%)
$21.12M(+34.7%)
Sep 2016
-
$15.68M(-10.8%)
Jun 2016
-
$17.58M(-9.7%)
Mar 2016
-
$19.46M(-31.4%)
Dec 2015
$28.36M(+57.7%)
$28.36M(+47.0%)
Sep 2015
-
$19.29M(+76.1%)
Jun 2015
-
$10.95M(-33.6%)
Mar 2015
-
$16.49M(-8.3%)
Dec 2014
$17.98M(+63.4%)
$17.98M(+15.1%)
Sep 2014
-
$15.63M(+16.2%)
Jun 2014
-
$13.45M(+36.3%)
Mar 2014
-
$9.87M(-10.4%)
Dec 2013
$11.01M(+7.5%)
$11.01M(+25.4%)
Sep 2013
-
$8.78M(-7.2%)
Jun 2013
-
$9.46M(+75.7%)
Mar 2013
-
$5.38M(-47.4%)
Dec 2012
$10.24M(+23.4%)
$10.24M(+94.8%)
Sep 2012
-
$5.26M(-15.1%)
Jun 2012
-
$6.19M(+15.9%)
Mar 2012
-
$5.34M(-35.6%)
Dec 2011
$8.30M(+27.2%)
$8.30M(+24.8%)
Sep 2011
-
$6.65M(+116.6%)
Jun 2011
-
$3.07M(-34.0%)
Mar 2011
-
$4.65M(-28.7%)
Dec 2010
$6.52M(+38.9%)
$6.52M(+92.3%)
Sep 2010
-
$3.39M(-36.7%)
Jun 2010
-
$5.36M(+10.6%)
Mar 2010
-
$4.84M(+3.1%)
Dec 2009
$4.70M(-17.8%)
$4.70M(-15.4%)
Sep 2009
-
$5.55M(-16.6%)
Jun 2009
-
$6.66M(-10.6%)
Mar 2009
-
$7.45M(+30.4%)
Dec 2008
$5.71M
$5.71M(-17.1%)
Sep 2008
-
$6.88M(+20.5%)
Jun 2008
-
$5.72M(+1.5%)
DateAnnualQuarterly
Mar 2008
-
$5.63M(+25.0%)
Dec 2007
$4.51M(+5.1%)
$4.51M(0.0%)
Sep 2007
-
$4.51M(+8.3%)
Jun 2007
-
$4.16M(+27.1%)
Mar 2007
-
$3.27M(-23.6%)
Dec 2006
$4.29M(+104.7%)
$4.29M(+42.8%)
Sep 2006
-
$3.00M(-8.1%)
Jun 2006
-
$3.27M(+31.6%)
Mar 2006
-
$2.48M(+18.5%)
Dec 2005
$2.10M(-69.9%)
$2.10M(-26.1%)
Sep 2005
-
$2.83M(+23.3%)
Jun 2005
-
$2.30M(+2.5%)
Mar 2005
-
$2.24M(-67.8%)
Dec 2004
$6.97M(+87.3%)
$6.97M(+147.2%)
Sep 2004
-
$2.82M(-17.5%)
Jun 2004
-
$3.42M(+2.0%)
Mar 2004
-
$3.35M(-10.0%)
Dec 2003
$3.72M(-32.7%)
$3.72M(+71.3%)
Sep 2003
-
$2.17M(-42.6%)
Jun 2003
-
$3.78M(+30.9%)
Mar 2003
-
$2.89M(-47.7%)
Dec 2002
$5.52M(-9.8%)
$5.52M(-51.5%)
Sep 2002
-
$11.38M(+256.0%)
Jun 2002
-
$3.20M(-44.9%)
Mar 2002
-
$5.80M(-5.3%)
Dec 2001
$6.13M(+174.6%)
$6.13M(+107.7%)
Sep 2001
-
$2.95M(+5.1%)
Jun 2001
-
$2.81M(-15.7%)
Mar 2001
-
$3.33M(+49.2%)
Dec 2000
$2.23M(-28.0%)
$2.23M(+204.8%)
Sep 2000
-
$732.00K(-35.4%)
Jun 2000
-
$1.13M(-12.9%)
Mar 2000
-
$1.30M(-58.0%)
Dec 1999
$3.10M(+3.3%)
$3.10M(+72.2%)
Sep 1999
-
$1.80M(-33.3%)
Jun 1999
-
$2.70M(0.0%)
Mar 1999
-
$2.70M(-10.0%)
Dec 1998
$3.00M(+7.1%)
$3.00M(+7.1%)
Sep 1998
-
$2.80M(+3.7%)
Jun 1998
-
$2.70M(+125.0%)
Mar 1998
-
$1.20M(-57.1%)
Dec 1997
$2.80M(+16.7%)
$2.80M(+154.5%)
Sep 1997
-
$1.10M(-21.4%)
Jun 1997
-
$1.40M(-41.7%)
Mar 1997
-
$2.40M(0.0%)
Dec 1996
$2.40M(+140.0%)
$2.40M(+166.7%)
Sep 1996
-
$900.00K(+28.6%)
Jun 1996
-
$700.00K(-36.4%)
Mar 1996
-
$1.10M(+10.0%)
Dec 1995
$1.00M(-33.3%)
$1.00M(+25.0%)
Sep 1995
-
$800.00K(+33.3%)
Jun 1995
-
$600.00K(-57.1%)
Mar 1995
-
$1.40M(-6.7%)
Dec 1994
$1.50M(+7.1%)
$1.50M(+15.4%)
Sep 1994
-
$1.30M(+30.0%)
Jun 1994
-
$1.00M(+11.1%)
Mar 1994
-
$900.00K(-35.7%)
Dec 1993
$1.40M(+40.0%)
$1.40M(+55.6%)
Sep 1993
-
$900.00K(+80.0%)
Jun 1993
-
$500.00K(-16.7%)
Mar 1993
-
$600.00K(-40.0%)
Dec 1992
$1.00M(-16.7%)
$1.00M(+66.7%)
Sep 1992
-
$600.00K(-25.0%)
Jun 1992
-
$800.00K(-38.5%)
Mar 1992
-
$1.30M(+8.3%)
Dec 1991
$1.20M
$1.20M(+200.0%)
Sep 1991
-
$400.00K(-69.2%)
Jun 1991
-
$1.30M(+225.0%)
Mar 1991
-
$400.00K

FAQ

  • What is Ionis Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals annual accounts payable year-on-year change?
  • What is Ionis Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals quarterly accounts payable year-on-year change?

What is Ionis Pharmaceuticals annual accounts payable?

The current annual accounts payable of IONS is $42.96M

What is the all time high annual accounts payable for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high annual accounts payable is $42.96M

What is Ionis Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, IONS annual accounts payable has changed by +$16.94M (+65.07%)

What is Ionis Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of IONS is $17.46M

What is the all time high quarterly accounts payable for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high quarterly accounts payable is $42.96M

What is Ionis Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, IONS quarterly accounts payable has changed by +$4.37M (+33.44%)
On this page